BRIEF-Geron provides updates to imetelstat clinical development
July 31, 2017 at 20:04 PM EDT
* Expects imbark protocol-specified primary analysis to begin no later than q3 of 2018 Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.